Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer

Clinical trial NCT05329532 · RECRUITING

Trial details

NCT number: NCT05329532
Sponsor: Scancell Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Renal Cell Cancer High Grade Ovarian Serous Adenocarcinoma Squamous Cell Carcinoma of the Head and Neck

Start date: 2022-04-07
Primary completion: 2026-07-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.